Literature DB >> 2168965

The immunogenicity of VP7, a rotavirus antigen resident in the endoplasmic reticulum, is enhanced by cell surface expression.

M E Andrew1, D B Boyle, P L Whitfeld, L J Lockett, I D Anthony, A R Bellamy, G W Both.   

Abstract

The glycoprotein VP7, the major serotype antigen of rotaviruses, is localized to the endoplasmic reticulum (ER) of the cell, where it is retained as a membrane-associated protein before assembly into mature virus particles. Wild-type VP7 expressed by a recombinant vaccinia virus was also located internally and was poorly antigenic. Using recombinant techniques, a correctly processed, secreted form of VP7 (S.C. Stirzaker and G.W. Both, Cell 56:741-747, 1989) was modified by addition to its C terminus of the membrane anchor and cytoplasmic domains from the influenza virus hemagglutinin. The hybrid protein was directed to the surface of cells, where it was anchored in the plasma membrane. When expressed in mice and rabbits by a recombinant vaccinia virus, the surface-anchored antigen stimulated a level of rotavirus-specific antibodies that was greater than 100-fold above the level induced by wild-type VP7. T-cell responses to the novel antigen were also elevated in comparison with the wild-type, intracellular protein. Cell surface anchoring may provide a strategy to increase the immunogenicity of intracellular antigens from other parasites and viruses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168965      PMCID: PMC247965          DOI: 10.1128/JVI.64.10.4776-4783.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

Review 2.  Rotavirus gene structure and function.

Authors:  M K Estes; J Cohen
Journal:  Microbiol Rev       Date:  1989-12

3.  Plasmodium knowlesi sporozoite antigen: expression by infectious recombinant vaccinia virus.

Authors:  G L Smith; G N Godson; V Nussenzweig; R S Nussenzweig; J Barnwell; B Moss
Journal:  Science       Date:  1984-04-27       Impact factor: 47.728

4.  General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

Authors:  M Mackett; G L Smith; B Moss
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

5.  NH2-terminal hydrophobic region of influenza virus neuraminidase provides the signal function in translocation.

Authors:  T J Bos; A R Davis; D P Nayak
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.

Authors:  D Panicali; E Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

7.  Multiple-cloning-site plasmids for the rapid construction of recombinant poxviruses.

Authors:  D B Boyle; B E Coupar; G W Both
Journal:  Gene       Date:  1985       Impact factor: 3.688

8.  Activation of virus specific CTL clones: antigen-dependent regulation of interleukin 2 receptor expression.

Authors:  M E Andrew; A M Churilla; T R Malek; V L Braciale; T J Braciale
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

9.  Deletions into an NH2-terminal hydrophobic domain result in secretion of rotavirus VP7, a resident endoplasmic reticulum membrane glycoprotein.

Authors:  M S Poruchynsky; C Tyndall; G W Both; F Sato; A R Bellamy; P H Atkinson
Journal:  J Cell Biol       Date:  1985-12       Impact factor: 10.539

10.  Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones.

Authors:  L A Morrison; A E Lukacher; V L Braciale; D P Fan; T J Braciale
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

View more
  7 in total

1.  Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies.

Authors:  A Pekosz; C Griot; K Stillmock; N Nathanson; F Gonzalez-Scarano
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

2.  Membrane binding and endoplasmic reticulum retention sequences of rotavirus VP7 are distinct: role of carboxy-terminal and other residues in membrane binding.

Authors:  M L Clarke; L J Lockett; G W Both
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

3.  Identification of a T-helper cell epitope on the rotavirus VP6 protein.

Authors:  D M Baños; S Lopez; C F Arias; F R Esquivel
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

4.  Structure of rotavirus outer-layer protein VP7 bound with a neutralizing Fab.

Authors:  Scott T Aoki; Ethan C Settembre; Shane D Trask; Harry B Greenberg; Stephen C Harrison; Philip R Dormitzer
Journal:  Science       Date:  2009-06-12       Impact factor: 47.728

5.  Transmissible gastroenteritis virus (TGEV)-based vectors with engineered murine tropism express the rotavirus VP7 protein and immunize mice against rotavirus.

Authors:  Juan Manuel Ribes; Javier Ortego; Juan Ceriani; Rebeca Montava; Luis Enjuanes; Javier Buesa
Journal:  Virology       Date:  2010-11-21       Impact factor: 3.616

6.  Recombinant outer capsid glycoprotein (VP7) of rotavirus expressed in insect cells induces neutralizing antibodies in rabbits.

Authors:  M Khodabandehloo; M Shamsi Shahrabadi; H Keyvani; B Bambai; Za Sadigh
Journal:  Iran J Public Health       Date:  2012-05-31       Impact factor: 1.429

Review 7.  Rotaviruses: immunological determinants of protection against infection and disease.

Authors:  P A Offit
Journal:  Adv Virus Res       Date:  1994       Impact factor: 9.937

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.